Probiotic foods and drugs: Impact of US regulatory status on design of clinical trials

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 2, 2008, Pages

  Hibberd, Patricia L ^a,b   Davidson, Lisa ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALTERNATIVE MEDICINE; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HUMAN; PRIORITY JOURNAL; SAFETY; UNITED STATES;

CLINICAL TRIALS AS TOPIC; CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; GOVERNMENT REGULATION; HEALTH FOOD; HUMANS; LEGISLATION, DRUG; LEGISLATION, FOOD; PROBIOTICS; QUALITY CONTROL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 40049085247     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523321     Document Type: Conference Paper

References (24)

1. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41.
2. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121:580-91.
3. Nase L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001; 35:412-20.
4. Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). Am J Clin Nutr 2003; 77:517-20.
5. Hilton E, Rindos P, Isenberg HD. Lactobacillus GGvaginal suppositories and vaginitis. J Clin Microbiol 1995; 33:1433.
6. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9.
7. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992; 14:11-6.
8. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000; 54:263-7.
9. Chiang BL, Sheih YH, Wang LH, Liao CK, Gill HS. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2000; 54:849-55.
10. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004; 126:1358-73.
11. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64:5403-5.
12. Schultz M, Linde HJ, Lehn N, et al. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 2003; 70:165-73.
13. Metchnikoff E. The prolongation of life. London: Putnam's Sons, 1908.
14. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324:1361.
15. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124:1202-9.
16. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22.
17. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-51.
18. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States 2002. Semin Integr Med 2004; 2:54-71.
19. Agheyisi R. Probiotics: ingredients, supplements, foods. 2005. Available at: http://www.bccresearch.com/RepTemplate.cfm? reportIDp235&RepDetpHLT&catpfod&targetprepdetail.cfm. Accessed 14 December 2007.
20. National Institutes of Health. CRISP: computer retrieval of information on scientific projects. Available at: http://crisp.cit.nih.gov/. Accessed 13 March 2007.
21. National Institutes of Health. ClinicalTrials.gov. Available at: http://clinicaltrials.gov/. Accessed 23 February 2007.
22. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004; 2:CD003048.
23. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134:657-62.
24. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry botanical drug products. 15 June 2004. Available at: http://www.fda.gov/cder/guidance/ 4592fnl.htm. Accessed 19 March 2007.